For lung cancer, TLE1 participates in the progression of lung cancer by enhancing epithelial mesenchymal transition of lung cancer cells by inhibiting E‐cadherin expression (Yao et al., 2014). This evidence concerns the gene CDH1 and lung carcinoma.